Apply Now for AACR Cancer Research Awards

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 10
Volume 5
Issue 10

The American Association for Cancer Research (AACR) has announced the availability of its four annual research awards. The Gertrude Elion award, provided through an educational grant from Glaxo Wellcome Oncology, is open to nontenured cancer researchers in clinical, basic, or translational research in the United States and Canada.

The American Association for Cancer Research (AACR) has announcedthe availability of its four annual research awards. The GertrudeElion award, provided through an educational grant from GlaxoWellcome Oncology, is open to nontenured cancer researchers inclinical, basic, or translational research in the United Statesand Canada.

The two 1997 Research Fellowships in Clinical/Translational Research,sponsored by Amgen, Inc. and Bristol-Myers Squibb Oncology, andthe 1997 Research Fellowship in Basic Research will go to scientistswho have been postdoctoral or clinical fellows at an academicinstitution in the United States or Canada for at least, but notmore than, 5 years.

A completed application form and sponsorship by an AACR memberare required for each award. The application deadline is February14, 1997. For application forms, contact Jenny Anne Horst-Martzby phone: 215-440-9300; fax: 215-440-9313; or e-mail: aacr@aol.com.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content